Health
Early interferon therapy may mitigate COVID-19 severity – News-Medical.Net
A recent review of COVID-19 therapies explores the utility of interferons in the battle against severe COVID-19, and concludes that they deserve further development….
The coronavirus disease 2019 (COVID-19) pandemic has now spread for over 10 months, evading capture by effective antivirals. The earliest vaccines are still in phase III of their clinical trials. Remdesivir is among the very few drugs that show even moderate benefit in this illness.
A recent review of COVID-19 therapies published in the journal International Immunopharmacologyin November 2020 explores the utility of interferons in the battle against severe COVID-19, and concludes that they deserve…
-
Business21 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Business21 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Noosa News18 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats